about
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillationCardiac innervation and sudden cardiac death.A danger of induction of Brugada syndrome during pill-in-the-pocket therapy for paroxysmal atrial fibrillation.Predictive factors of lead failure in patients implanted with cardiac devices.Optimal conditions for cardiac catheter ablation using photodynamic therapy.Electrical superior vena cava isolation using photodynamic therapy in a canine model.A novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome.Diagnostic Accuracy of Commercially Available Automated External DefibrillatorsEmbryonic type Na+ channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome.The Role of Circadian Rhythms in Fatal Arrhythmias and the Potential Impact of Intervention for Sleep-Disordered Breathing.Disease characterization using LQTS-specific induced pluripotent stem cells.A cost-utility analysis for catheter ablation of atrial fibrillation in combination with warfarin and dabigatran based on the CHADS2 score in Japan.Report of the American Heart Association (AHA) Scientific Sessions 2015, Orlando.Left atrial strain is a powerful predictor of atrial fibrillation recurrence after catheter ablation: study of a heterogeneous population with sinus rhythm or atrial fibrillation.Mitral isthmus ablation using a circular mapping catheter positioned in the left atrial appendage as a reference for conduction block.Effect of Nocturnal Intermittent Hypoxia on Left Atrial Appendage Flow Velocity in Atrial Fibrillation.Operator-blinded contact force monitoring during pulmonary vein isolation using conventional and steerable sheaths.Genome-wide association study of electrocardiographic parameters identifies a new association for PR interval and confirms previously reported associations.Recurrent Torsade de Pointes during mild hypothermia therapy for a survivor of sudden cardiac arrest due to drug-induced long-QT syndrome.A case of Brugada syndrome showing augmentation of electrocardiogram phenotype by complete right bundle branch block.Ventricular fibrillation associated with J-wave manifestation following pericarditis after catheter ablation for paroxysmal atrial fibrillation.Electrophysiological properties of the superior vena cava and venoatrial junction in patients with atrial fibrillation: relevance to catheter ablation.Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings.Effect of Compliance to Updated AHA/ACC Performance and Quality Measures Among Patients With Atrial Fibrillation on Outcome (from Japanese Multicenter Registry).Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores.Real-Time Analysis of the Heart Rate Variability During Incremental Exercise for the Detection of the Ventilatory Threshold.Response by Fujisawa et al to Letter Regarding Article, "Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension".Pulmonary Artery Denervation by Determining Targeted Ablation Sites for Treatment of Pulmonary Arterial Hypertension.A Novel SCN5A Mutation Found in a Familial Case of Long QT Syndrome Complicated by Severe Left Ventricular Dysfunction.An RyR2 mutation found in a family with a short-coupled variant of torsade de pointes.Assessment of atrial fibrillation ablation outcomes with clinic ECG, monthly 24-h Holter ECG, and twice-daily telemonitoring ECG.Risk factors for early replacement of cardiovascular implantable electronic devices.Clinical characteristics of atrial fibrillation detected by implanted devices and its association with ICD therapy.Suppression of Rad leads to arrhythmogenesis via PKA-mediated phosphorylation of ryanodine receptor activity in the heart.Improvement in the electrocardiograms associated with right ventricular hypertrophy after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.Cor triatriatum sinister: an incidental finding in a patient with paroxysmal atrial fibrillationA Homozygous Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular TachycardiaAnti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndromePrevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathyTrans-telephonic ICD alert due to recommended replacement time notification: what is the problem?
P50
Q24320049-B6CF5217-AE28-410E-A8A1-A89E45244C74Q27339391-6EB39592-F9ED-4B77-B81C-B63F742DE707Q33160177-0F70CC79-64CC-408F-A904-1481BD5E455AQ33166054-8579A764-FFA0-42A6-8D81-40E517240C5AQ35539123-0E75906C-E15B-4876-9AB3-26F2B32082F1Q35590742-8EE2ED69-74C9-451B-8291-9A3EA36631A3Q36158650-976432F0-D201-488B-8DAE-C60D06098725Q36836489-F3699D74-5600-4467-9255-312776CE4251Q37291478-BD36EB57-7B31-41C4-B6CE-80F3795A9688Q38542980-0BF61133-EE67-4DE7-815F-43055E3C959BQ39595974-DB130A4A-3773-4D11-9A56-5E9990D37E27Q39944925-C80BE565-BD6C-4532-B594-6872A656BE7DQ41050900-50B1090A-3134-4ADF-BB13-252D73B4AA0CQ41270570-BC688A0A-319B-4B5A-AA63-1443F8B0755FQ41592872-A6239BB6-A65A-4DEC-83EE-0C21BBA9C801Q41753931-7A95C1E1-290C-43B5-8893-C283A75FCCD3Q41756416-42773572-A030-4A25-9D25-0F6DD59EE623Q42673573-6B83968F-B455-48E6-932D-D2089D1769A0Q43257494-3E8C64BF-52B1-4C1C-B700-A75BC6D7E27AQ43550564-5E26798A-4198-4556-9549-AAC235AF95FFQ44042093-72FD6EED-0C03-4B82-B0AA-23F569E2BA68Q46076060-7F22B389-BD6E-42A3-BC21-D47249FED87AQ47161289-78BECE53-F1B0-4768-9451-4D9334E410E3Q47557573-07EB9873-17ED-4DD5-84AA-87B5795DFF9FQ48174863-FC43DD56-3212-4866-B1C2-D79172C146DEQ49603762-02189B82-14E8-4CAB-84D0-EACE5D6EE6A8Q49683337-539EEA35-A05E-4112-A9C6-6BB7ACFD1BCDQ50085403-9BB71DF1-CD99-4F5C-928E-4880ADF3355CQ51239891-A92DF1EA-A836-435F-A66C-B0CD0895A5E9Q51329742-F2C96309-ABAC-47DC-8266-F14FE20796EBQ53065807-06009184-F2DE-42BA-8206-F91B40429B78Q53372049-94B9F9F9-FC52-4C79-B2E4-BEB0C8565615Q53627115-3BABB3BD-C2C3-4F93-9E00-1E4ADBD6FD41Q54324683-B0850023-D354-41AA-A0AD-0EF7A135BCD2Q55395563-60EFB0C2-E433-4602-A0E8-F76597D4A2E2Q57644092-D9838BC9-16CD-4D90-B18C-8ED68A930120Q61800544-A5AF3987-E4BA-4A4E-9224-E2957DE2187DQ81506801-9DAAC24C-E4CB-44FF-BD3E-2ED8ABA35D8AQ82658704-C8097929-5436-4069-A6F2-736D16C8C662Q82764033-218FE81B-0C76-43DD-8A4F-E4B2352BEAD2
P50
description
researcher ORCID ID = 0000-0002-8323-4229
@en
wetenschapper
@nl
name
Yoshiyasu Aizawa
@ast
Yoshiyasu Aizawa
@en
Yoshiyasu Aizawa
@es
Yoshiyasu Aizawa
@nl
type
label
Yoshiyasu Aizawa
@ast
Yoshiyasu Aizawa
@en
Yoshiyasu Aizawa
@es
Yoshiyasu Aizawa
@nl
prefLabel
Yoshiyasu Aizawa
@ast
Yoshiyasu Aizawa
@en
Yoshiyasu Aizawa
@es
Yoshiyasu Aizawa
@nl
P108
P108
P31
P496
0000-0002-8323-4229